201 related articles for article (PubMed ID: 15258572)
41. Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment.
Yamanaka H; Gatanaga H; Kosalaraksa P; Matsuoka-Aizawa S; Takahashi T; Kimura S; Oka S
J Infect Dis; 2007 May; 195(10):1419-25. PubMed ID: 17436221
[TBL] [Abstract][Full Text] [Related]
42. Sequence analysis of familial PEO shows additional mutations associated with the 752C-->T and 3527C-->T changes in the POLG1 gene.
Lamantea E; Zeviani M
Ann Neurol; 2004 Sep; 56(3):454-5. PubMed ID: 15349879
[No Abstract] [Full Text] [Related]
43. A multi-systemic mitochondrial disorder due to a dominant p.Y955H disease variant in DNA polymerase gamma.
Siibak T; Clemente P; Bratic A; Bruhn H; Kauppila TES; Macao B; Schober FA; Lesko N; Wibom R; Naess K; Nennesmo I; Wedell A; Peter B; Freyer C; Falkenberg M; Wredenberg A
Hum Mol Genet; 2017 Jul; 26(13):2515-2525. PubMed ID: 28430993
[TBL] [Abstract][Full Text] [Related]
44. DNA polymerase gamma, the mitochondrial replicase.
Kaguni LS
Annu Rev Biochem; 2004; 73():293-320. PubMed ID: 15189144
[TBL] [Abstract][Full Text] [Related]
45. Identification of amino acids important for target recognition by the DNA:m5C methyltransferase M.NgoPII by alanine-scanning mutagenesis of residues at the protein-DNA interface.
Radlinska M; Kondrzycka-Dada A; Piekarowicz A; Bujnicki JM
Proteins; 2005 Feb; 58(2):263-70. PubMed ID: 15558546
[TBL] [Abstract][Full Text] [Related]
46. Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma.
Filosto M; Mancuso M; Nishigaki Y; Pancrudo J; Harati Y; Gooch C; Mankodi A; Bayne L; Bonilla E; Shanske S; Hirano M; DiMauro S
Arch Neurol; 2003 Sep; 60(9):1279-84. PubMed ID: 12975295
[TBL] [Abstract][Full Text] [Related]
47. Neuromelanin MRI in a family with mitochondrial parkinsonism harboring a Y955C mutation in POLG1.
Mukai M; Sugaya K; Yabe I; Goto Y; Yokochi F; Miyamoto K; Cai H; Sasaki H; Matsubara S
Parkinsonism Relat Disord; 2013 Sep; 19(9):821-4. PubMed ID: 23673011
[TBL] [Abstract][Full Text] [Related]
48. Concerted action of two novel tRNA mtDNA point mutations in chronic progressive external ophthalmoplegia.
Kornblum C; Zsurka G; Wiesner RJ; Schröder R; Kunz WS
Biosci Rep; 2008 Apr; 28(2):89-96. PubMed ID: 18384291
[TBL] [Abstract][Full Text] [Related]
49. Early-onset familial parkinsonism due to POLG mutations.
Davidzon G; Greene P; Mancuso M; Klos KJ; Ahlskog JE; Hirano M; DiMauro S
Ann Neurol; 2006 May; 59(5):859-62. PubMed ID: 16634032
[TBL] [Abstract][Full Text] [Related]
50. A theoretical model of restriction endonuclease NlaIV in complex with DNA, predicted by fold recognition and validated by site-directed mutagenesis and circular dichroism spectroscopy.
Chmiel AA; Radlinska M; Pawlak SD; Krowarsch D; Bujnicki JM; Skowronek KJ
Protein Eng Des Sel; 2005 Apr; 18(4):181-9. PubMed ID: 15849215
[TBL] [Abstract][Full Text] [Related]
51. Autosomal dominant chronic progressive external ophthalmoplegia: a tale of two genomes.
Shoubridge EA
Ann Neurol; 1996 Nov; 40(5):693-4. PubMed ID: 8957008
[No Abstract] [Full Text] [Related]
52. A novel processive mechanism for DNA synthesis revealed by structure, modeling and mutagenesis of the accessory subunit of human mitochondrial DNA polymerase.
Fan L; Kim S; Farr CL; Schaefer KT; Randolph KM; Tainer JA; Kaguni LS
J Mol Biol; 2006 May; 358(5):1229-43. PubMed ID: 16574152
[TBL] [Abstract][Full Text] [Related]
53. Structure-function defects of the twinkle amino-terminal region in progressive external ophthalmoplegia.
Holmlund T; Farge G; Pande V; Korhonen J; Nilsson L; Falkenberg M
Biochim Biophys Acta; 2009 Feb; 1792(2):132-9. PubMed ID: 19084593
[TBL] [Abstract][Full Text] [Related]
54. A single tyrosine prevents insertion of ribonucleotides in the eukaryotic-type phi29 DNA polymerase.
Bonnin A; Lázaro JM; Blanco L; Salas M
J Mol Biol; 1999 Jul; 290(1):241-51. PubMed ID: 10388570
[TBL] [Abstract][Full Text] [Related]
55. Effect of the Y955C mutation on mitochondrial DNA polymerase nucleotide incorporation efficiency and fidelity.
Estep PA; Johnson KA
Biochemistry; 2011 Jul; 50(29):6376-86. PubMed ID: 21696159
[TBL] [Abstract][Full Text] [Related]
56. The activity of selected RB69 DNA polymerase mutants can be restored by manganese ions: the existence of alternative metal ion ligands used during the polymerization cycle.
Zakharova E; Wang J; Konigsberg W
Biochemistry; 2004 Jun; 43(21):6587-95. PubMed ID: 15157091
[TBL] [Abstract][Full Text] [Related]
57. [A familial case of chronic progressive external ophthalmoplegia associated with mitochondrial disease].
Patte M; Dalens H; Sole P; Sole M; Clavelou P; Boespflug-Tangy O; Beaufrère AM; Bacin F
J Fr Ophtalmol; 2001 Nov; 24(9):961-5. PubMed ID: 11912841
[TBL] [Abstract][Full Text] [Related]
58. The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit.
Chan SS; Longley MJ; Copeland WC
J Biol Chem; 2005 Sep; 280(36):31341-6. PubMed ID: 16024923
[TBL] [Abstract][Full Text] [Related]
59. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.
Naviaux RK; Nguyen KV
Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711
[TBL] [Abstract][Full Text] [Related]
60. Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in mitochondrial DNA replication.
Kasiviswanathan R; Longley MJ; Chan SS; Copeland WC
J Biol Chem; 2009 Jul; 284(29):19501-10. PubMed ID: 19478085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
